The First Hearing Loss Cure? FX-322 Update | Frequency Therapeutics - podcast episode cover

The First Hearing Loss Cure? FX-322 Update | Frequency Therapeutics

Jan 05, 20226 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

FX-322 is a new pharmaceutical research drug aimed at finding a hearing loss cure. The research group Frequency Therapeutics created FX 322 to help find a cure for individuals with hearing loss. In this episode, I share an update on the research.

For the best experience, listen in Metacast app for iOS or Android